Cita APA

Taniuchi, K., Furihata, M., Naganuma, S., & Saibara, T. (2018). WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4. Cancer Med.

Citación estilo Chicago

Taniuchi, Keisuke, Mutsuo Furihata, Seiji Naganuma, y Toshiji Saibara. "WAVE2 Is Associated With Poor Prognosis in Pancreatic Cancers and Promotes Cell Motility and Invasiveness Via Binding to ACTN4." Cancer Med 2018.

Cita MLA

Taniuchi, Keisuke, Mutsuo Furihata, Seiji Naganuma, y Toshiji Saibara. "WAVE2 Is Associated With Poor Prognosis in Pancreatic Cancers and Promotes Cell Motility and Invasiveness Via Binding to ACTN4." Cancer Med 2018.